Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.95−0.02 (-2.05%)
Close on Nov 20, 2026Market cap $18.30MP/E –Yield –
Cocrystal Pharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2012 it was $7.22M, up 168.9% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $7.22M | +168.9% |
| FY2011 | Dec 31, 2011 | $2.69M | -60.7% |
| FY2010 | Dec 31, 2010 | $6.83M | – |
See a number that looks wrong?